Gestamp Automocion (0ROM)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.913 |
|---|---|
| 52-week range | 2.770 – 3.500 |
| Return, 1 month / 3 months | −4.8% / +3.4% |
| Return, 1 year / 3 years | −8.9% / −13.0% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 26.3% |
| Worst drawdown (1 year) | -17.8% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gestamp Automocion is a Spanish automotive supplier that designs and manufactures metal components and structural parts for vehicles. Its products include body-in-white parts, chassis components and mechanisms used in cars and light commercial vehicles. The company serves major car manufacturers around the world from production plants in Europe, the Americas and Asia, and it is based in Spain.
Gestamp Automocion trades under the code 0ROM on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gestamp Automocion (0ROM) trades on the London Exchange in UK. It last closed at EUR 2.913 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,233 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.9% and over the last three months it rose 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.8% | ||
| From 52-week high | -15.6% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.4% | ||
| 6-month return | -7.3% | ||
| 12-month return, skipping the last month | -4.3% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.8% | ||
| Liquidity | 11 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 16.7% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | −4.8% |
| 3 months | +3.4% |
| 6 months | −7.3% |
| 1 year | −8.9% |
| 3 years | −13.0% |
| 5 years | −8.3% |
Signals
| 50-day / 200-day average | 2.966 / 3.027 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.109 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | EUR 0.0334 |
| 12 Jan 2026 | EUR 0.0317 |
| 30 Jun 2025 | EUR 0.0414 |
| 10 Jan 2025 | EUR 0.0392 |
| 1 Jul 2024 | EUR 0.0626 |
| 8 Jan 2024 | EUR 0.0567 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.